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Background
Binding of the gp120/gp41 complex to CD4/coreceptors
is cooperative, requiring three CD4 binding events, four
to six coreceptors, and multiple clusters of gp120/gp41
to effectively form a fusion pore.[1] An engineered CD4
mimetic mini protein (miniCD4) [2] and the third vari-
able region (V3) of gp120 [3] are peptides able to block
HIV entry.
Gold nanoparticles covered with carbohydrates, pep-
tides or proteins are useful tools to study biological pro-
cesses where multivalence is crucial. [4] In this work we
present the study of the multimerization of miniCD4and
V3 peptides onto gold glyconanoparticles (GNPs).
Materials and methods
To prepare the GNPs we used a strategy developed in
our laboratory. [5,6] MiniCD4 and V3 peptides were
linked to the GNPs by covalent bond or by electrostatic
interaction. In the covalent bond procedure carboxyl
groups on GNPs were activated with NHS/EDC to react
with amine groups of lysines present in the peptides.
The so-obtained peptide-GNP complexes were charac-
terized by
1HNMR, UV, TEM, gel electrophoresis and
MALDI and the tri-dimensional structure of the pep-
tides on the GNPs was studied by circular dichroism
(CD).
The binding of miniCD4-GNPs to gp120 and the
interaction of V3-GNPs to anti-V3 monoclonal antibody
447-52D were studied by SPR using ProteOn XPR36.
The effect of V3-GNPs on the levels of coreceptors
CCR5 and CXCR4 on cell surface was tested by flow
cytometry after incubation with U87.CD4.CCR5 and
U87.CD4.CXCR4cells.
HIV neutralization experiments were performed using
TZMBL cell line stably transfected with CD4 and both
CCR5 and CXCR4. Cells were incubated in the presence
or absence of GNPs with IIIB or Bal virus.
Results
The amount of peptides on GNPs depends on their nat-
ure (e.g. number of lysine and charged amino acids) and
on the GNP preparation protocols. CD experiments
showed that miniCD4 peptide on GNPs does not change
its conformation. However, V3 coupled to GNPs
changes the conformation from essentially random coil
to a-helix as indicated by the CD spectra. Conjugation
of miniCD4 or V3 to the GNPs did not affect the bind-
ing ability of the peptides to the selected receptors
(gp120 and anti-V3 447-52D mAb, respectively) as
showed by SPR sensograms.
Flow cytometry data showed that incubation of U87.
CD4.CXCR4 cells with V3 peptide or V3-GNPs decrease
the level of CXCR4 on cell surface, while GNP control
without peptides gave CXCR4 level comparable to the
untreated control. V3-GNPs decrease CXCR4 level 5
times more than free peptide. MiniCD4-GNPs inhibit
the infection as well as the free peptide in preliminary
HIV neutralization experiments.
Conclusions
M i n i C D 4 - G N P sa r ea b l et ob i n dg p 1 2 0b u tn om u l t i v a -
lent effect was observed. Experiments with V3-GNPs
gave encouraging results in the binding to both corecep-
tor and mAb, making these GNPs interesting tools to
study their immunogenic properties and the effect on
coreceptor sequestration.
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